title: Alloantigen system L affects the outcome of rous sarcomas.
abstract: This study was designed to examine the alloantigen system L effects on Rous sarcomas in three B complex genotypes. The parental stock was 50% Modified Wisconsin Line 3 x White Leghorn Line NIU 4 and 50% inbred Line 6.15-5. Pedigree matings of two B(2)B(5) L(1)L(2) sires to five B(2)B(5) L(1)L(2) dams per sire produced experimental chicks segregating for B and L genotypes. Chicks were inoculated with 20 pock-forming units (pfu) of Rous sarcoma virus (RSV) at 6 weeks of age. Tumors were scored six times over 10 weeks postinoculation after which the tumor scores were used to assign a tumor profile index (TPI) to each chicken. Tumor growth over time and TPI were evaluated by repeated-measures analysis of variance and analysis of variance, respectively. Six trials were conducted with a total of 151 chickens. The major histocompatibility (B) complex affected the responses as the B(2)B(2) and B(2)B(5) genotypes had significantly lower tumor growth over time and TPI than the B(5)B(5) genotype. Separate analyses revealed no significant L system effect in B(2)B(2) or B(2)B(5) backgrounds. However, L genotype significantly affected (P < 0.05) both tumor growth over time and TPI in B(5)B(5) chickens. B(5)B(5) L(1)L(2) birds had TPI significantly lower than B(5)B(5) L(1)L(1) chickens but not B(5)B(5) L(2)L(2). Mortality was lower in the B(5)B(5) L(1)L(2) birds than in B(5)B(5) L(2)L(2) chickens. The L system, or one closely linked, affects the growth and ultimate outcome of Rous sarcomas. The response may depend upon the genetic background as well as MHC type.
authors.affiliation: Department of Animal and Nutritional Sciences, University of New Hampshire, Durham, New Hampshire 03824, USA.
authors.forename: Zdravka
authors.initials: Z
authors.lastname: Medarova
authors.forename: W Elwood
authors.initials: WE
authors.lastname: Briles
authors.forename: Robert L
authors.initials: RL
authors.lastname: Taylor
mesh_terms: D000818:Animals; D002645:Chickens; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006649:Histocompatibility Antigens / Q000235:genetics / Q000276:immunology*; D011379:Prognosis; D001357:Sarcoma, Avian / Q000235:genetics / Q000276:immunology* / Q000401:mortality / Q000503:physiopathology
chemical_list: D006649:Histocompatibility Antigens